Author details

Full Name

Frauke Zipp

Affiliation

ORCID

Career Start Year

1989

Papers

358

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36657567	Interleukin-4 as a therapeutic target.		2023
36323361	Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: Analysis of 49 autoantibodies in over 7000 subjects.	Brain, Behavior, and Immunity	2023
36319190	Association of obesity with disease outcome in multiple sclerosis.	J Neurol Neurosurg Psychiatry	2023
36411080	Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort.	Neurology: Neuroimmunology and NeuroInflammation	2023
36318271	Early spinal cord pseudoatrophy in interferon-beta-treated multiple sclerosis.	Eur J Neurol	2023
37743753	Strict blood pressure control following thrombectomy is associated with neuronal injury and poor functional outcome.		2023
37642541	Prognostic value of single-subject grey matter networks in early multiple sclerosis.		2023
38074649	Case Report: Balancing immune responses - multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanoma.		2023
37703825	IL-17 receptor goes solo in autoimmune inflammation.		2023
37702323	Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury.	Clin Chem Lab Med	2023
37692259	Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.	Ther Adv Neurol Disord	2023
37957728	Spatial transcriptomics and neurofilament light chain reveal changes in lesion patterns in murine autoimmune neuroinflammation.		2023
36715759	EGFL7 loss correlates with increased VEGF-D expression, upregulating hippocampal adult neurogenesis and improving spatial learning and memory.	Cell Mol Life Sci	2023
36631830	Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension.		2023
37384112	Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial.		2023
37430070	Implications of immunometabolism for smouldering MS pathology and therapy.		2023
37236189	Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis.		2023
36535106	Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosis.		2023
37163992	Cytokines as emerging regulators of central nervous system synapses.		2023
34764215	Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis.	Neurology: Neuroimmunology and NeuroInflammation	2022
35587822	Interleukin-4 receptor signaling modulates neuronal network activity.	Journal of Experimental Medicine	2022
35582936	Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis.	European Journal of Neurology	2022
35760867	AgRP neurons control feeding behaviour at cortical synapses via peripherally derived lysophospholipids.	Nature Metabolism	2022
35700670	Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies.	Multiple Sclerosis and Related Disorders	2022
35442704	Inhibition of the enzyme autotaxin reduces cortical excitability and ameliorates the outcome in stroke.	Science Translational Medicine	2022
35440092	Preventing disease progression in multiple sclerosis-insights from large real-world cohorts.	Genome Medicine	2022
35813883	Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkers.	Brain Communications	2022
35732103	T cell-neuron interaction in inflammatory and progressive multiple sclerosis biology.	Current Opinion in Neurobiology	2022
35674071	Progression in multiple sclerosis - a long-term problem.	Current Opinion in Neurology	2022
35610651	Network alterations underlying anxiety symptoms in early multiple sclerosis.	Journal of Neuroinflammation	2022
36568489	Comparative effectiveness of natalizumab ocrelizumab in multiple sclerosis: a real-world propensity score-matched study.		2022
34967456	Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis.	Ann Neurol	2022
34417310	Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammation.	Proceedings of the National Academy of Sciences of the United States of America	2021
34297142	[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)].	Der Nervenarzt	2021
34180982	The potential of serum neurofilament as biomarker for multiple sclerosis.	Brain	2021
33959194	Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis.	Therapeutic Advances in Neurological Disorders	2021
33949707	Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2.	Annals of Neurology	2021
34104217	Serum neurofilament levels reflect outer retinal layer changes in multiple sclerosis.	Therapeutic Advances in Neurological Disorders	2021
34261812	Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.	Neurology: Neuroimmunology and NeuroInflammation	2021
33983376	The neuroinflammation collection: a vision for expanding neuro-immune crosstalk in Brain.	Brain	2021
33762428	Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial.	Neurol Neuroimmunol Neuroinflamm	2021
33556229	Neurofilament light chain levels reflect outcome in a patient with glutamic acid decarboxylase 65 antibody-positive autoimmune encephalitis under immune checkpoint inhibitor therapy.	European Journal of Neurology	2021
34298735	Targeting Immune Modulators in Glioma While Avoiding Autoimmune Conditions.	Cancers (Basel)	2021
33376202	Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.	Proc Natl Acad Sci U S A	2021
33150829	High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients.	Multiple Sclerosis Journal	2021
32646538	Neuropsychological Symptoms After Anterior Cerebral Artery Ischemic Stroke.	Canadian Journal of Neurological Sciences	2021
33140401	Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug-resistant epilepsy.	Epilepsia	2021
34992484	A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk Factors.		2021
34571362	NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study.	eBioMedicine	2021
34457039	Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders.	Therapeutic Advances in Neurological Disorders	2021